The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses - Scuoppo, Claudio; Ramirez, Rick; Leong, Siok F.; Koester, Mark; Mattes, Zachary F.; Mendelson, Karen; Diehl, Julia; Abbate, Franco; Gallagher, Erin; Ghamsari, Lila; Vainstein-Haras, Abi; Merutka, Gene; et al. (Frontiers in Immunology, 2025)